Entecavir and Hepatitis B Immune Globulin in Patients Undergoing Liver Transplantation for Chronic Hepatitis B

For patients undergoing liver transplantation (LT) for hepatitis B virus (HBV)–related liver disease, the current standard of care for preventing reinfection of the allograft is nucleoside analogue therapy combined with hepatitis B immune globulin (HBIG). Entecavir has demonstrated high efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrillo, Robert, Buti, Maria, Durand, Francois, Charlton, Michael, Gadano, Adrian, Cantisani, Guido, Loong, Che-Chuan, Brown, Kimberly, Hu, Wenhua, Lopez-Talavera, Juan Carlos, Llamoso, Cyril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791551/
https://www.ncbi.nlm.nih.gov/pubmed/23788462
http://dx.doi.org/10.1002/lt.23690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791551/
https://www.ncbi.nlm.nih.gov/pubmed/23788462
http://dx.doi.org/10.1002/lt.23690

Ejemplares similares